OncoStem – startup that helps to identify personalised breast cancer recurrence risks

▴ Breast cancer risk identification
OncoStem develops innovative prognostic tests for assessing aggressiveness of tumours in the breast. The test is known as CanAssist Breast Test. It helps in identifying the unique characteristics of cancer recurrence risk so that oncologists are able to design evidence-based treatment plans.

OncoStem’s CanAssist Breast Test examines the activity of proteins present in the cancerous tumour to predict the likelihood of recurrence of cancer of the breast post- surgery. It also helps determine which therapy would be more conducive for the patient - chemotherapy or just the hormone therapy, thus customizing the treatment. Manjiri Bakre is the CEO and Founder of OncoStem which was launched in the year 2011. She is a cell biology and cell signaling expert with more than 25 years of experience in research and technology in India, Singapore and the US. OncoStem is a product of her vision of developing and delivering cost effective, reliable and innovative diagnosis tests for designing customized cancer treatment plans. 

How does CanAssist Breast Test work?

In order to compute the risk of recurrence of cancer, a proteomics-based method and a proprietary machine learning-based algorithm is utilized to analyze a patented combination of protein biomarkers from the patient’s tumour. IHC (immunohistochemistry) data and clinical parameters are then used to calculate the risk score that classifies patients in high or low-risk categories. CanAssist Breast Test results also help low risk breast cancer patients to potentially avoid chemotherapy and its side effects. Once OncoStem’s laboratory receives the tumour sample, the reports can be shared with the oncologist within 10 working days.

Recognitions for innovative solution

Manjiri has won many awards for powerful stint in entrepreneurship like the Indian Achievers' Award 2021 for “Entrepreneur of the Year”, Top 25 voices in Precision Medicine Asia 2020 – BIS Research and Insight Monk, Startupreneur Award 2020 in the Pharma and Biotech Category by CII, Woman Entrepreneur of the year 2019, "25 Dominant Leaders to Watch in Health Care Industry 2019" - Startup City India, Aegis Graham Bell Awards 2021 in the Innovative Diagnostic Solutions Category etc. There are many publications and patents as well to her name.

Functioning and future plans of OncoStem

300+ oncologists, 10+ hospitals and diagnostics chains such as Oncquest, Dr Lal PathLabs, SRL are part of the organization’s network through which it functions. The startup aims to facilitate digital pathology solutions so that complete automation and decentralisation of the services are possible. This will make testing possible for any hospital in the world in their own laboratory. OncoStem is also doing robust research to develop similar tests for other cancer types including triple-negative breast cancer and ovarian cancer.

Tags : #oncostem #canassistbreasttest #cancerrecurrencetest #riskcalculation #smitaprasad #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Worldwide EndoMarch, Endo Run to raise mass awareness on Endometriosis!February 21, 2024
Uptick In Respiratory, and Cardiac Problems Due To Poor Air Quality In DelhiFebruary 21, 2024
Evidence shows risks associated with energy drinks in childrenFebruary 21, 2024
iHub-Data at IT-Hyderabad announces collaborative initiative with technical institutions for AI/ML training programsFebruary 20, 2024
Viatris Receives Global Minimized Risk of Antimicrobial Resistance Certification, Advancing its Commitment to Responsible Antibiotic ProductionFebruary 20, 2024
“Kusum Ka Biyaah” Indian Hindi film based on a true story releasing on 1st March 2024February 19, 2024
Introducing Moscow's Pioneering Initiative: An Open Dataset for AI-driven Brain Disease Detection"February 19, 2024
ICPA Health Products Introduces Coolora Spray - A Rapid Relief Solution For Oral & Throat DiscomfortFebruary 19, 2024
Section 43B of the Income Tax demystifiedFebruary 16, 2024
Nutricircle Introduces Health Supplements My45NutrientsTM to Enhance Overall Well-beingFebruary 16, 2024
YFLO organised a session “Design Your Story” to inspire young FICCI Ladies to design their own compelling storiesFebruary 15, 2024
149 experts call to find all TB to stop TBFebruary 15, 2024
ICPA Welcomes Global Leader In Periodontal Aesthetics - Prof Giovanni Zucchelli On His Inaugural Visit To IndiaFebruary 14, 2024
Fast Fashion and Sustainability are not friends and do not go well with each other: Namrata Joshipura, one of India’s most celebrated Fashion designers February 14, 2024
YFLO to organise a session Design Your StoryFebruary 14, 2024
Starkey Launches Genesis AI Hearing Aids in India, Pioneering a New Era in Hearing HealthFebruary 14, 2024
Indian Institute of Heritage and University of Birmingham announce strategic partnershipFebruary 14, 2024
Siddharth Anand’s Fighter emerges as the first hit of 2024February 13, 2024
India’s 26 years old youth’s Adventurous Atal Yatra to Celebrate Silver Jubilee of the Golden Quadrilateral beginsFebruary 13, 2024
Vitafoods India 2024 - Exploring Nutraceutical FrontiersFebruary 13, 2024